Inspira Technologies Ltd., an innovative medical technology company, revealed its revolutionary respiratory support system, the AXT, it directly oxygenates the blood and stabilizes, the patient oxygen levels eliminating the need for mechanical ventilation.
Inspira announced that it filed a patent application for its new AXT system, as a preventive treatment to avoid the use of invasive mechanical ventilation. During the course Inspria revealed the AXT system as the world’s first system, to directly oxygenate blood and remove carbon dioxide, all while leaving a patient awake, alert, and breathing to their capacity – which can all be done outside of the ICU.
The AXT system is five times smaller than invasive mechanical ventilation machines allowing mobility, simplicity, and flexibility. It is easy to use with a plug & play connection system. The frame is made of medical-grade aluminum and magnesium, making it highly durable. The system’s smart and beautifully lit touchscreen is divided, into three main operational zones: the patient’s vital signs, the system controls and various data collected from the patient’s surrounds. A user-friendly operational dial located below the screen.
The AXT system also has in-built-self-initiation technology developed by the Company, which eliminates the need for specialized technicians or medical staff for its operation.
The system includes several innovative blood oxygenation features, including the ability to automatically adjust its performance based on patient information and vital signs.
Yigal Kassif, MD. Chairman, Israel ECMO Society & Cardiac Surgeon, Sheba Medical Center said: “Inspira’s AXT system is a fundamental game-changer in the field of blood oxygenation. This smart, affordable and simple to use system will make treatment more accessible and at a much earlier stage of treatment, far less invasive, much safer and more effective. My colleagues and I are more than excited to implement this new technology and provide better care to our patients.”